Condition
Parkinson's Disease (PD)
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 107 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson DiseaseNCT07705373 · 2026-08-20
RECRUITINGSTN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's DiseaseNCT07774312 · 2026-07-27
RECRUITINGThe Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseNCT07610369 · 2026-07-10
RECRUITINGThe Effects of Tele-Rehabilitation-Based Dual-Task Upper Extremity Training in Patients With Parkinson's DiseaseNCT07641556 · 2026-07-01
RECRUITINGA Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSANCT07604116 · 2026-06-15
RECRUITINGComparison of Two Different Dual-Task Training Methods in Patients With Parkinson's DiseaseNCT07641569 · 2026-06-15
RECRUITINGMusic Therapy in Parkinson's DiseaseNCT07734181 · 2026-06-02
RECRUITINGBiomechanical Effects of EMST® on Swallowing Function in Parkinson's DiseaseNCT07606547 · 2026-06-01
RECRUITINGA Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's DiseaseNCT07322887 · 2026-05-21
RECRUITINGSubthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's DiseaseNCT07625540 · 2026-05-20
RECRUITINGExoskeleton-Assisted Mobility in Aging and in Parkinson's DiseaseNCT07567482 · 2026-04-30
RECRUITINGRemote Haptic Rehabilitation for Parkinson's DiseaseNCT07457710 · 2026-03-25
RECRUITINGLFP-based Parameter Prediction in DBS for Parkinson's DiseaseNCT07485621 · 2026-03-05
RECRUITINGEfficacy of LSVT-LOUD Therapy on Voice, Speech, and Quality of Life in Parkinson's DiseaseNCT07730073 · 2026-02-18
RECRUITINGInvestigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator RecipientsNCT07455760 · 2026-02-18
RECRUITINGEffects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's DiseaseNCT07226284 · 2026-02-10
RECRUITINGA Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBDNCT07790744 · 2026-02-01
RECRUITINGElectrophysiology-based DBS Programming for PDNCT07348705 · 2026-01-15
RECRUITINGA Study of Buntanetap in Participants With PDNCT07284784 · 2026-01-09
RECRUITINGEffects of the Stimulation Site of tsMS With TMS on Functional Mobility in Individuals With Parkinson's DiseaseNCT07488026 · 2026-01-05
RECRUITINGPharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal ApproachNCT07316296 · 2026-01-01
RECRUITINGBiofluid Research on Age-Related or Inherited NeurodegenerationNCT07798700 · 2025-12-12
RECRUITINGLIFUS For Neurological DisordersNCT07417280 · 2025-12-02
RECRUITINGNon-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's DiseaseNCT07244640 · 2025-11-01
RECRUITINGResearch Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's DiseaseNCT07310264 · 2025-10-30
RECRUITINGThis Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.NCT07830654 · 2025-09-25
RECRUITINGA Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's DiseaseNCT07170475 · 2025-06-27
RECRUITINGCerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease TremorNCT06993571 · 2025-04-16
RECRUITINGShanghai Clinical Cohort - Parkinson's Disease (Reserve)NCT07353463 · 2025-04-01
RECRUITINGEmpower Your Mind to Embrace Your Life: an Online ACT Intervention for Young-Onset Parkinson's DiseaseNCT07310147 · 2025-04-01
RECRUITING[18F]ACI-15916 PET in α-synucleinopathiesNCT06891703 · 2025-03-20
RECRUITINGPairing Subjective Patient Rating and DBS ProgrammingNCT07336199 · 2024-12-02
RECRUITINGQuantification of Hsp90 in the Human BrainNCT07380204 · 2024-09-04
RECRUITINGAcupuncture and Moxibustion for Motor Symptoms in Early Parkinson's DiseaseNCT06874803 · 2024-08-01
RECRUITINGClosed-loop TMS for TremorNCT07574164 · 2024-01-01
RECRUITINGA Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.NCT07630545 · 2023-11-30
RECRUITINGImpact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's DiseaseNCT07568951 · 2023-08-01
RECRUITINGMoving Yourself in Space and Time: MYSTICNCT07697664 · 2022-03-25
RECRUITINGComprehensive Assessment of Neurodegeneration and DementiaNCT03402919 · 2016-06-01
RECRUITINGTerazosin And Metabolic Energetics in Parkinson's DiseaseNCT07464028 · 2028-07-01
SUSPENDEDZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's DiseaseNCT07718659 · 2026-12-01
NOT_YET_RECRUITINGA Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's DiseaseNCT07647614 · 2026-12-01
NOT_YET_RECRUITINGCoordinated Reset Deep Brain Stimulation for Parkinson's DiseaseNCT07340073 · 2026-10-10
NOT_YET_RECRUITINGEffects of Transcutaneous Cervical Vagus Nerve Stimulation on Non-motor Symptoms in Parkinson's DiseaseNCT07839481 · 2026-09-30
NOT_YET_RECRUITINGBlood Flow Restriction Aerobic Exercise for Balance and Anxiety in Parkinson's DiseaseNCT07831980 · 2026-09-28
NOT_YET_RECRUITINGMild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.NCT07214974 · 2026-09-01
NOT_YET_RECRUITINGInvestigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson DiseaseNCT07808346 · 2026-08-29
ACTIVE_NOT_RECRUITINGPhase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's DiseaseNCT07741045 · 2026-08-03
NOT_YET_RECRUITINGAAV2-hAADC for Parkinson's Disease (PDCS-01)NCT07267065 · 2026-08-01
NOT_YET_RECRUITINGA Study of Dimdazenil in Patients With Parkinson's Disease and InsomniaNCT07714772 · 2026-08-01
NOT_YET_RECRUITINGA Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 MutationsNCT07685444 · 2026-07-07
NOT_YET_RECRUITINGImmediate Effects of External Trigeminal Nerve Stimulation on Motor Dysfunction in Parkinson's DiseaseNCT07656129 · 2026-06-15
NOT_YET_RECRUITINGAutomated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's DiseaseNCT07215481 · 2026-06-01
NOT_YET_RECRUITINGUnderstanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and NeuroimagingNCT07474779 · 2026-05-11
NOT_YET_RECRUITINGPhase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning SurgeryNCT07550374 · 2026-05-01
NOT_YET_RECRUITINGClinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic NucleusNCT07533591 · 2026-05-01
NOT_YET_RECRUITINGEffects of Cognitive Dual-Task on Gait in Parkinson's DiseaseNCT07540325 · 2026-04-20
NOT_YET_RECRUITINGPilot Study of Robotic Spinal Mobilization in Parkinson's DiseaseNCT07376122 · 2026-03-09
NOT_YET_RECRUITINGEffects Of Strategy Training And PNF On Balance, Gait, And Independence In Parkinson's DiseaseNCT07484451 · 2026-03-01
NOT_YET_RECRUITINGMovement State-dependent Adaptive DBS for PDNCT07424508 · 2026-02-04
ENROLLING_BY_INVITATIONCommon interventions
PlaceboDRUG16BIA 9-1067DRUG7ABBV-951DRUG6ADS-5102DRUG2BIA 3-202DRUG2PlaceboOTHER2[11C]HSP990 PET dosimetryOTHER1[11C]HSP990 PET test-retestOTHER1[11C]HSP990 simplified scan protocolOTHER1[18F]ACI-15916OTHER1[18F]AV-133DRUG1[18F]MK-0947DRUG1[18F]T807 ([18F]MNI-777)DRUG1120 milligrams of ENERGI-F705 TabletsDRUG160 milligrams of ENERGI-F705 TabletsDRUG1AAV2-hAADCDRUG1Active-tACSDEVICE1Acupuncture and Moxibustion (AM)PROCEDURE1adaptive DBS (aDBS)DEVICE1Aerobic Exercise with Blood Flow RestrictionBEHAVIORAL1Aerobic Exercise without Blood Flow RestrictionBEHAVIORAL1AgeOTHER1ampreloxetineDRUG1AtomoxetineDRUG1BackHug Robotic Spinal Mobilization SystemDEVICE1
Leading sponsors
AbbVie
11
Bial - Portela C S.A.
11
University of Minnesota
3
Adamas Pharmaceuticals, Inc.
2
Boston University Charles River Campus
2
Pacla Medical Limited
2
Ruijin Hospital
2
Saglik Bilimleri Universitesi
2
Second Affiliated Hospital, Zhejiang University, School of Medicine
2
Universitaire Ziekenhuizen KU Leuven
2
AC Immune SA
1
Annovis Bio Inc.
1
Atlas University
1
Bastyr University
1
Boston Scientific Corporation
1
Trial status mix
RECRUITING39
COMPLETED36
NOT_YET_RECRUITING21
ACTIVE_NOT_RECRUITING5
ENROLLING_BY_INVITATION2
TERMINATED2
SUSPENDED1
WITHDRAWN1
Phase mix
NA41
PHASE122
PHASE311
PHASE29
EARLY_PHASE15
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.